Related Experiment Videos
Malignant hyperpyrexia during anaesthesia: possible association with subclinical myopathy
British Medical Journal
|January 31, 1970
Summary
Serum creatine phosphokinase tests revealed high levels in relatives of patients with malignant hyperpyrexia. This suggests a subclinical myopathy, potentially inherited, that can cause life-threatening reactions to anesthesia.
Area of Science:
- Anesthesiology
- Genetics
- Neurology
Background:
- Malignant hyperpyrexia is a rare, life-threatening pharmacogenetic disorder of skeletal muscle.
- Previous cases of malignant hyperpyrexia deaths occurred within this family during anesthesia.
Purpose of the Study:
- To investigate the genetic basis of malignant hyperpyrexia in a family with a history of anesthetic deaths.
- To identify potential biomarkers for predicting susceptibility to malignant hyperpyrexia.
Main Methods:
- Serum creatine phosphokinase (CPK) levels were measured in family members.
- Autosomal dominant inheritance patterns were analyzed.
Main Results:
- Elevated serum CPK levels were detected in numerous asymptomatic family members.
- These findings suggest a subclinical myopathy present in a significant portion of the family.
Conclusions:
- Abnormal serum CPK levels may indicate a subclinical myopathy with a propensity for malignant hyperpyrexia.
- This condition appears to be inherited in an autosomal dominant pattern.
- Investigating family members of affected individuals could aid in anticipating future malignant hyperpyrexia cases.